EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Wien, 22.2.2019 Overview

1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Event changing the breakdown of voting rights Other
3. Person subject to notification obligation
Acting in concert (Sec. 133 No. 7 BörseG 2018)

____________________________________________________________________________
|___First_name____|____Name/Surname_____|________City_________|___Country____|
|Mohammed_________|Al_Sheikh____________|_____________________|______________|
|Abdulmohsen______|Al_Sheikh____________|_____________________|______________|
| |Acropora Beteiligungs|Wien |Österreich |
|_________________|GmbH_________________|_____________________|______________|

4. Name of shareholder(s):
5. Date on which the threshold was crossed or reached: 20.2.2019
6. Total positions

______________________________________________________________________________
| | | % of voting | | |
| | % of voting |rights through |Total of both |Total number of|
| |rights attached|financial/other| in % (7.A + | voting rights |
| |to shares (7.A)| instruments | 7.B) | of issuer |
|_______________|_______________|(7.B.1_+_7.B.2)|______________|_______________|
| Resulting | | | | |
| situation on | | | | |
| the date on | 23,27 % | 0,00 % | 23,27 % | 1 430 772 |
|which threshold| | | | |
| was crossed / | | | | |
|____reached____|_______________|_______________|______________|_______________|
| Position of | | | | |
| previous | 26,42 % | | | |
| notification | | | | |
|(if_applicable)|_______________|_______________|______________|_______________|

Details
7. Notified details of the resulting situation:

______________________________________________________________________________
|A:_Voting_rights_attached_to_shares___________________________________________|
| |____Number_of_voting_rights____|_______%_of_voting_rights_______|
| | Direct | Indirect | Direct | Indirect |
| ISIN Code |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 BörseG |
|_____________|_____2018)_____|_____2018)_____|_____2018)_____|_____2018)______|
|ATMARINOMED6_|________332_910|_______________|________23,27_%|________________|
|_SUBTOTAL_A__|____________332_910____________|____________23,27_%_____________|

______________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG |
|2018__________________________________________________________________________|
| | | |Number of voting | |
| | | | rights that may | |
| Type of | | | be | % of voting |
| instrument |Expiration Date|Exercise Period|acquired if the | rights |
| | | | instrument is | |
|_____________|_______________|_______________|____exercised____|______________|
|_____________|_______________|_SUBTOTAL_B.1__|_________________|______________|

_____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
|2018_________________________________________________________________________|
| Type of | Expiration | Exercise | Physical / | Number of |% of voting |
|instrument | Date | Period | Cash |voting rights| rights |
|___________|____________|___________|_Settlement__|_____________|____________|
|___________|____________|___________|SUBTOTAL_B.2_|_____________|____________|

8. Information in relation to the person subject to the notification obligation:
Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

_____________________________________________________________________________
| | | | | Financial/ | |
| | | Directly | Shares held | other |Total of both|
| No. | Name |controlled |directly (%) | instruments | (%) |
| | | by No. | |held directly| |
|__________|____________|___________|_____________|_____(%)_____|_____________|
| 1 |Abdulmohsen | | | | |
|__________|Al_Sheikh___|___________|_____________|_____________|_____________|
| 2 |Mohammed Al | | | | |
|__________|Sheikh______|___________|_____________|_____________|_____________|
| |Acropora | | | | |
| 3 |Beteiligungs| 1,2 | 23,27 %| | 23,27 %|
|__________|GmbH________|___________|_____________|_____________|_____________|

9. In case of proxy voting
Date of general meeting: –
Voting rights after general meeting: – is equivalent to – voting rights. 10. Sonstige Kommentare:
Die Beteiligungsmeldung erfolgt aufgrund der Schwellenunterschreitung wegen der Kapitalerhöhung (Wandlung von ISIN AT00A1WD52)
Wien am 22.2.2019

end of announcement euro adhoc

issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English

Digital press kit: http://www.ots.at/pressemappe/31479/aom